Arzoxifene
- Generic Name
- Arzoxifene
- Drug Type
- Small Molecule
- Chemical Formula
- C28H29NO4S
- CAS Number
- 182133-25-1
- Unique Ingredient Identifier
- E569WG6E60
- Indication
Investigated for use/treatment in breast cancer, osteoporosis, and endometrial cancer.
LY353381 in Preventing Breast Cancer in Women With Hyperplasia
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 199
- Registration Number
- NCT00005879
- Locations
- 🇺🇸
U.S. Oncology Research, Inc., Dallas, Texas, United States
🇺🇸University of Kansas Medical Center, Kansas City, Kansas, United States
Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.
Phase 3
Completed
- Conditions
- Breast Neoplasms
- First Posted Date
- 2002-04-24
- Last Posted Date
- 2006-07-19
- Lead Sponsor
- Eli Lilly and Company
- Registration Number
- NCT00034125
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath